Editorial Board ::: Infectious Disorders - Drug Targets

ISSN: 2212-3989 (Online)
ISSN: 1871-5265 (Print)


Volume 17, 3 Issues, 2017


Download PDF Flyer




Infectious Disorders - Drug Targets

Formerly: Current Drug Targets - Infectious Disorders

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Jean-Marc Sabatier
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20
France


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Editorial Board

Editor-in-Chief:

Jean-Marc Sabatier (Biography
Jean-Marc Sabatier

Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry.

)

Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20
France



Co-Editor:

Zhijan Cao (Biography
Zhijan Cao

Dr. Cao is a professor from College of Life Sciences, Wuhan University, China. He has nearly 20 years of experience in the research of animal toxin peptides, involving in cDNA, genome, biological and pharmacological roles (such as anti-virus, anti-tumor, ion-channel-modulating), molecular diversity and evolution. Dr. Cao graduated Ph.D from College of Life Sciences, Wuhan University, China in 2004. He was a visiting scholar of Meharry Medical College, USA from 2014 to 2015. Notably, Dr. Cao has authored more than 100 manuscripts and 12 patents. He was an Excellent Young Scholar of China National Science Fund in 2014 and got Youth Science and Technology Award from Chinese Society of Toxicology in 2016.

)

Visiting scholar
Meharry Medical Collage
USA


Founding Editor:

Robert Goldman (Biography
Robert Goldman

Dr. Goldman received his PhD in Microbiology from the University of California, Los Angeles and completed postdoctoral training at the University of Massachusetts Medical Center, Worchester, MA. He was then awarded the prestigious Leverhulme Fellowship to teach and pursue research at Trinity College, Dublin, Ireland. Returning to the United States Dr. Goldman accrued 4 years advanced training in infectious disease research at the National Institutes of Health (NIH), Bethesda, MD. He then joined Abbott Laboratories, Chicago, IL were he spent 16 years discovering and developing anti-infective agents, and continued this work as Director of Biology, Incara Research Labs, Princeton, NJ, before returning to the NIH for 14 years, focusing on discovery and development of new TB drugs. Dr. Goldman is currently a private consultant (RGC Consulting), senior advisor to Valaria Technical Consultants and a member of the Scientific Advisory Board for the Lilly-NIH TB Drug Discovery Initiative. Dr. Goldman was the Founding Editor and Editor-in-Chief for Infectious Disorder – Drug Targets (2000-2007). He has authored 79 peer-reviewed publications and 18 invited reviews.

)

RGC Consulting
Wimauma, FL
USA


Associate Editors:

Tommy R. Tong (Biography
Tommy R. Tong

Prof. Tong obtained his medical degrees (M.B.,B.S., MD) from the University of Hong Kong and the University of the State of New York. He has also American Board of Pathology-certified and fellowship-trained at Memorial Sloan Kettering Cancer Center. Currently, he is Clinical Professor of Pathology at City of Hope Comprehensive Cancer Center. He has published multiple peer-reviewed scientific articles, owns 4 U.S. patents and named co-inventor in a pending U.S. patent application. He is on the editorial board of multiple journals, as well as associate editor of this journal, published by Bentham Science Publishers.

)

Department of Pathology, Montefiori Medical Center
Bronx, NY
USA

M. Tumbarello
Catholic University of the Sacred Heart
Rome
Italy


Regional Editors:

A.R. Amin
Virginia College of Osteopathic Medicine (VCOM)
VA
USA

I. Qadri (Biography
I. Qadri

Dr. Ishtiaq Qadri obtained his PhD degree in Biotechnology from the Imperial College of Science and Technology, London, UK. Later on, he completed several years of postdoctoral training from the university of California San Francisco, CA, USA. He is an active researcher involved in the study of viral-induced pathogenesis and has served in many top academic positions in US, Pakistan and Saudi Arabia. He is the founding Director General of National Center of Virology and Immunology which was sponsored by HEC, Pakistan and US-State Dept. Dr. Qadri has completed 30 research grants and 170 research publications and is Editor in chief of and Editor of over a dozen International journals

)

King Abdul Aziz University
Jeddah
Saudi Arabia


Section Editors:

(Microbiology)
T.A. Black
Infectious Diseases, Merck Research Laboratories
Kenilworth, NJ
USA

(Virology, HIV)
E. Loret
Lab. Retrovirology, Faculté de Pharmacie
Marseille Cedex 5
France

(Microbiology)
Prof. Jinglin Wang
The Laboratory of Toxinology
Beijing Institute of Microbiology and Epidemiology
Beijing
China

(Microbiology)
L.E. Hensley
US Army Medical Research Institute of Infectious Diseases
Maryland
USA

(Virology, SARS)
T.R. Tong
Dep. Path. Montefiori Med. Center North Div.
Bronx, NY
USA


Editorial Board Members:

Hourieh ALKADI
Faculty of Science
Damascus University Damascus
Syria

D. Andreotti (Biography
D. Andreotti

Dr. D. Andreotti obtained his degree in Chemistry from the University of Ferrara, Italy, in addition Dr. Andreotti also holds a further qualification as Specialist in Organic Synthesis from University of Milan, Italy. Dr. Andreotti has got about 30 years of experience in the Drug Discovery field with a particular focus on the antibacterial side. He has published more than 65 scientific publications including papers and patents. Since 2015 Dr. Andreotti is member of the Editorial Board Member of IDDT journal.

)

GlaxoSmithkline Res. Centre
Verona
Italy

Y. Cheng
Yale University
New Haven, CT
USA

P. Clapham
University of Massachusetts Medical School
Worcester, MA
USA

SHAHBAZZADEH Delavar
Dept of Biotechnology
Pasteur Institute of Iran
Iran

F. Doucet-Populaire
University of Paris
Paris
France

G. Gregoriadis
University London
London
UK

D. Kahne
Harvard University
Boston, MA, NJ
USA

H. Maltezou (Biography
H. Maltezou

Dr. Maltezou received her Medical Diploma in 1991 from the University of Crete, Greece, and had her post-doctoral fellowship during 1994-1997 on viral infections in immunocompromised patients at M.D. Anderson Cancer Center, University of Texas, Houston, USA. In 2000 Dr. Maltezou received her PhD from the University of Crete in collaboration with the University of Texas (Thesis: Viral Infections in Children Undergoing Hematopoietic Stem Cell Transplants). During 1997-2001 Dr Maltezou was trained at the Pediatric Residency Program of the University of Athens, Greece, and subsequently, during 2001-2003, she was trained in infectious diseases at the Unite des Rickettsies, Universite de la Mediterannee, Marseille, France, as the 2001 recipient of the European Society for Pediatric Infectious Diseases Fellowship Award.

)

Hellenic Center for Disease Control and Prevention
Athens
Greece

I. Qadri
King Abdul Aziz University
Jeddah
Saudi Arabia

M.E. Selsted
Keck School of Medicine of USC
Los Angeles
USA

G.G. Stone
Pfizer Global Research and Development
Groton
USA

Z. Xiao-Lian (Biography
Z. Xiao-Lian

Dr. Zhang received a master degree of Virology and Molecular Biology (1986) from Wuhan University and Ph.D degree of Biochemistry (1997) from Hongkong University of Science and Technology. She did her postdoctoral training at Univ. of Maryland, College Park, MD, USA.

Now Dr. Zhang is chairman of Immunology Department, Director of Hubei Province Key Laboratory of Allergy and Immunology,“Luojia” distinguished professor of Wuhan University, Professor of State Key Laboratory of Virology at Wuhan University, China.

Dr. Zhang has long been focused on the research of infection immunology of intracellular pathogens. She discovered type IV pili gene operon and site-specific recombination enzyme gene on Salmonella typhi pathogen virulence island. She also found some key functions of glycan and glycosylation during pathogens (Hepatitis C Virus, Mycobacterium Tuberculosis) infection.

)

Department of Immunology, Wuhan University
China

C. Abad-Zapatero (Biography
C. Abad-Zapatero

Celerino Abad-Zapatero, Ph.D. Obtained a Licenciado degree in Physics from the University of Valladolid, Spain, and later a Ph.D.in Biophysics (Macromolecular Crystallography) from the University of Texas at Austin, sponsored by a Fulbright Scholarship. He was part of the team that unveiled the atomic structures of the first viruses (SBMV) in the early 1980’s with Michael Rossmann at Purdue University. He worked in the pharmaceutical industry (Abbott Laboratories) for twenty-two years using the methods of Structure-Based Drug Design to expedite the design and optimization of medicinal drugs. He retired from the private industry in 2008 and is currently Adjunct Professor to the Graduate Faculty at the University of Chicago.

)

Abbott Lab.
Abbott Park, IL
USA

Kamran P. Bagheri
Dept of Biotechnology
Pasteur Institute of Iran
Iran

Jean-Claude Chermann
URRMA R&D, Centre de Vie Agora
Aubagne Cedex
France

E.De. Clercq
Rega Institute for Medical Research,KU
Leuven
Belgium

Sumanta K. Dey (Biography
Sumanta K. Dey

Sumanta is currently holding the position of Postdoctoral Associate in the Department of Biological Engineering at Massachusetts Institute of Technology since 2013. His current studies are focused broadly on development of tools and their application to understand the biology of malaria parasites. One of his major goals is to explore essential genes in the malaria parasite using these tools and further develop high throughput antimalarial drug screening and drug target validation assay systems. Sumanta Dey received his PhD from the Jadavpur University in 2013 for his studies on mechanistic aspects of liver damage during blood stage of malaria.

)

Indian Institute of Chemical Biology Infectious Diseases and Immunology Division
Kolkata
India

B. Finlay
University British Colombia
Vancouver, BC
Canada

S. Ilyin
Johnson & Johnson Pharm Res and Dev.
Spring House, PA
USA

H. Kazemian (Biography
H. Kazemian

Hossein Kazemian was born in Ilam, west of Iran in 1988. He gained the first rank in Msc and PhD exam in Iran. He received his master of Medical microbiology in Tehran University of Medical Sciences, Tehran, Iran. His thesis was about Mycobacterium tuberculosis. He is PhD candidate (senior) of Medical Bacteriology in Tehran University of Medical Sciences.

Now, he is member of Clinical Microbiology Research Center in Ilam University of Medical Sciences, Iran and also Iranian society of microbiology. His main field is tuberculosis, Molecular genotyping, Antimicrobial resistance, Herbal Medicine, etc.

)

PhD of Medical Microbiology
Tehran University of Medical Sciences
Iran

M.C. O'Sullivan
Canisius College
Buffulo, NY
USA

F. Roohvand
Pasteur Institute of Iran
Tehran
Iran

I. Shinkai
Mitsui & Co. Ltd.
Tokyo
Japan

B. L. Tekwani (Biography
B. L. Tekwani

Principal Scientist & Professor of Pharmacology, National Center for Natural Products Research (NCNPR), School of Pharmacy, University of Mississippi, University, MS, USA. Leading Molecular Parasitology and in vitro/in vivo screening research related to the antiparasitic drug discovery programs at the NCNPR. Coordinator and Co-PI collaborative UM (NCNPR) and Walter Reed Army Institute of Research (WRAIR) drug discovery program (2001-till date).Focus of Research- Biochemistry and molecular biology of tropical disease pathogens (malaria, leishmaniasis and trypanosomiasis); Drug Metabolism; Neurodegenerative disorders; New drug discovery research; Pharmacokinetics, In vitro–in vivo drug metabolism, Molecular and functional characterization of potential targets enzymes, genes and metabolic pathways from malaria and leishmania parasites.

)

National Center for Natural Products Research
University of Mississippi
USA

Q. Zhao
Yale University School of Medicine
New Haven
USA

A. A. Y. Abouelfetouh (Biography
A. A. Y. Abouelfetouh

Dr. Abouelfetouh obtained an MSc (2007) and a PhD (2010) in Microbiology from Alexandria University studying biofilms as part of the mechanisms of antimicrobial resistance among bacteria. She was a bioVision.Nxt fellow (Lyon, 2011). She conducted two post-doctoral fellowships at Loyola University Chicago 2012-2013 on a Fulbright scholarship and Medical College of Wisconsin 2013-2014. Dr. Abouelfetouh is currently an associate Professor at the Faculty of Pharmacy, Alexandria University, Egypt where she teaches microbiology to Pharmacy students. She is the principal investigator of a number of projects studying antimicrobial resistance among clinical isolates. She has important publications in the field.

)

Alexandria University
Alexandria
Egypt

A. Branstrom
PTC Therapeutics
South Plainfield, NJ
USA

S. Chinikar
National Reference Laboratory
Tehran
Iran

H.L. Davis
Coley Pharm. Group,Ottawa
Ontario, ON
Canada

N.D. Djadid
Pasteur Institute of Iran
Tehran
Iran

O. Golubnitschaja (Biography
O. Golubnitschaja

Dr. Golubnitschaja, Department of Radiology, Medical Faculty of the Friedrich-Wilhelms- University in Bonn, Germany, has studied journalism, biotechnology and medicine and has been awarded fellowships for biomedical research in Paediatrics and Neurosciences (Medical Centres in Austria, Russia, UK, Germany, the Netherlands, and Switzerland). She is well-cited in the innovative research fields of predictive, preventive and personalised medicine. Dr. Golubnitschaja is an expert in molecular diagnostics actively publishing in the fields of ophthalmic diseases, neurodegenerative pathologies, cancer, cardiovascular disease, Diabetes mellitus, hyperhomocysteinemia, etc. She is the co-founder of the theory of individual patient profiles, author of fundamental works in systems medicine (holistic approach considering molecular patterns at epi/genomic, transcriptional and post/translational levels).

)

Friedrich-Wilhelms, University of Bonn
Germany

K-T. Jeang
Nat. Institute Health
Bethesda, MD
USA

W. Liu
Wuhan University
Wuhan
China

R.N. Ondarza (Biography
R.N. Ondarza

Professor of Biochemistry, Faculty of Medicine, Universidad Nacional Autonoma de Mexico,UNAM and Medical Researcher, Center of Research on Infectious Diseases, National Institute of Public Health Doctor in Biology (Biochemistry) Faculty of Sciences , UNAM, 1963. Fellow John Simon Guggenheim Memorial Foundation, 1963 Doctor Honoris causa, Universite du Paris Xlll, Republique Francaise, Ministere de l'Education Nationale, Academie de Creteil, 1984. Visiting Professor in four occasions, at Scripps Institution of Oceanography, University of California, San Diego at La Jolla, California, during his sabbatical years, 1964, 1982, 2002, 2005 and Visiting Researcher, Department of Chemistry, University of California, San Diego, at La Jolla, 1986. 50 scientific publications and 16 books.

)

Nat. Institute Public Health
Mexico

F. Scaglione
University of Milan
Milan
Italy

M.J. Sofia
Pharmasset, Incorporation
Princeton, NJ
USA

T. Wood (Biography
T. Wood

Tony leads Worldwide Research & Development’s Medicinal Sciences, a group that encompasses the small molecule and large molecule partner lines that enable and accelerate Pfizer’s end-to-end portfolio to deliver medicines and vaccines to patients.Prior to this appointment,Tony served as the the head of Worldwide Medicinal Chemistry. Tony also served as Head of Chemistry and Exploratory Medicinal Sciences in Sandwich from February 2007 and Head of Chemistry from April 2004. Tony joined Pfizer as a Scientist in the Department of Discovery Chemistry at Sandwich in 1992. Over the period of the next 8 years he made a number of contributions to the delivery of development candidates in various projects from within the Sexual Health, Urology, and Gastrointestinal Therapeutic Areas.

)

Pfizer Global Research and Development
Kent
UK


Advertisement
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals




Related eBooks



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science